Waters introduced two new mass spectrometers at ASMS
The Cyclic IMS P20 and Xevo MRT P10 set new benchmarks in structural/spatial omics and multiomics research.
See the latest news and media coverage for Waters. We track all announcements, press releases, and industry mentions in real time, all in one place.
Analytical laboratory instruments, consumables, and software
waters.comLast updated
In short: Waters completed its combination with BD's Biosciences and Diagnostic Solutions businesses, forecasting strong 2026 adjusted EPS and organic growth.
The Cyclic IMS P20 and Xevo MRT P10 set new benchmarks in structural/spatial omics and multiomics research.
The system reduces detection time by 3 hours and increases vial loading capacity by 50%.
The benchtop HRMS offers up to 20x higher MS/MS sensitivity and 2x faster speeds, enabling deeper biological insight.
The platform offers >10x MS/MS sensitivity, 50% extended mass range to >100 kDa, and integrated MALDI/DESI imaging with ion mobility.
Piper Sandler initiates Waters stock coverage with neutral rating...
On June 03, 2026, Waters Corporation WAT announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its BD BACTEC...
Wolfe Research initiates Waters stock with Outperform rating...
Waters Corporation (WAT) remains a 'Hold'—the merger's long-term value is still uncertain despite initial optimism and strong revenue growth.
Track Waters and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Waters and other trending companies.